H.R. 1988 · 112th Congress
Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DavisSponsor20 cosponsors · 20 D
D
Schwartz
DC
D
Cicilline
CV
D
Van Hollen
RN
D
Neal
RB
D
Brady
JC
D
Courtney
AC
D
Carson
GC
D
Connolly
MC
D
Critz
CF
D
Fattah
AH
D
Hastings
RH
D
Holt
MK
D
Kaptur
RK
D
Kind
WK
D
Keating
CM
D
McCarthy
BP
D
Pascrell
CR
D
Rangel
SR
D
Rothman
AS
D
Sires1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011 - Amends the Internal Revenue Code to extend for an additional five-year period the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities,…
What it does: CRS summary · Introduced in House · May 25, 2011
Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011 - Amends the Internal Revenue Code to extend for an additional five-year period the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities, clinical trials, and clinical studies, or by carrying out research projects to approve new drugs or other biologic products; (2) diagnose diseases or conditions to determine molecular factors related to diseases or conditions; or (3) develop a product, process, or technology to further the delivery or administration of therapeutics).
Extends for an additional five-year period the authority of the Secretary of the Treasury to award grants for investment in a qualifying therapeutic discovery project in lieu of a tax credit and the funding for such grants.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011
Latest action (Jun 3, 2011): Referred to the Subcommittee on Health.
Policy area: Taxation · Origin: House · Introduced: May 25, 2011
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.